Intangible Assets and Goodwill

3 Months Ended

Dec. 28, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets consisted of the following:



Description	As of December 28, 2019				As of September 28, 2019
Description	Gross Carrying Value		Accumulated Amortization		Gross Carrying Value		Accumulated Amortization
Acquired intangible assets:
Developed technology	$	3,909.3	$	2,716.7	$	3,927.7	$	2,654.8
Customer relationships	527.7		454.5		525.5		447.5
Trade names	244.7		173.6		245.4		171.1
Distribution agreement	—		—		2.5		—
Non-competition agreements	1.5		1.0		1.4		0.9
Business licenses	2.3		2.2		2.3		2.2
Total acquired intangible assets	$	4,685.5	$	3,348.0	$	4,704.8	$	3,276.5

Internal-use software	50.8		40.9		53.9		43.4
Capitalized software embedded in products	27.7		8.1		27.9		6.9
Total intangible assets	$	4,764.0	$	3,397.0	$	4,786.6	$	3,326.8

In the first quarter of fiscal 2020, the Company's Medical Aesthetics business met the criteria to be designated as assets held-for-sale. As a result, the Company recorded a $30.2 million charge to record the asset group at fair value less costs to sell. In addition, developed technology, customer lists, tradenames, and distribution agreement related to Medical Aesthetics of $24.1 million, $0.9 million, $2.0 million, and $1.2 million, respectively, were reclassified accordingly in the Company's Consolidated Balance Sheet to assets held-for-sale as of December 28, 2019.

The estimated remaining amortization expense of the Company's acquired intangible assets as of December 28, 2019 for each of the five succeeding fiscal years is as follows:



Remainder of Fiscal 2020	$	213.7
Fiscal 2021	$	263.6
Fiscal 2022	$	253.2
Fiscal 2023	$	155.8
Fiscal 2024	$	144.8